Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market to Grow at a CAGR of 5.7% from 2025 to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Size During 2025–2029?

The market valuation for devices addressing chronic obstructive pulmonary disease (COPD) and asthma has experienced robust expansion throughout the recent period, moving from a figure of $44.95 billion in 2024 to an anticipated $47.56 billion by 2025, reflecting a compound annual growth rate (CAGR) of 5.8%; this upward trajectory over the historical duration is linked to factors such as the expanding demographic of older individuals, a higher prevalence of allergic conditions, augmented governmental support programs, an escalation in clinical investigation and testing, coupled with increased levels of urbanization.

The substantial expansion projected for the Chronic Obstructive Pulmonary Disease (COPD) and asthma device sector is anticipated to continue robustly in the coming years, culminating in a valuation of $59.46 billion by the year 2029, driven by a compound annual growth rate of 5.7%. This upward trajectory throughout the projection timeframe is fundamentally linked to several key factors: the increasing incidence of respiratory ailments, the escalating rates of cigarette smoking, worsening environmental pollution and related breathing difficulties, the broader prevalence of respiratory conditions, augmented healthcare spending, and the enhanced portability featured in drug delivery mechanisms. Within this forecast window, significant shifts will be marked by ongoing technological progress, the incorporation of intelligent systems, tailored medical treatments, increased utilization of biologic therapies, and the deployment of wearable devices for monitoring respiratory functions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18298&type=smp

Which Factors And Drivers Are Influencing The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market In 2025?

Anticipated increases in the incidence of pulmonary maladies are projected to fuel the expansion of the market for devices designed to manage asthma and chronic obstructive pulmonary disease (COPD) in the near future.These respiratory ailments, which comprise numerous conditions affecting the lungs and their associated systems, including asthma, pneumonia, lung cancer, and COPD, significantly impair an individual’s ability to breathe and overall respiratory capability.The rising frequency of these illnesses can be attributed to escalating environmental pollution, shifts in global climatic conditions influencing the spread of allergens and infectious agents, and personal behaviors such as tobacco use that undermine lung resilience.Devices utilized for COPD and asthma are fundamental components in the holistic approach to treating and managing these respiratory conditions, enabling sufferers to attain superior pulmonary health and a better quality of life.To illustrate the severity, data released in March 2023 by the World Health Organization (WHO), the United Nations body dedicated to global health situated in Switzerland, established chronic obstructive pulmonary disease (COPD) as the third primary cause of mortality worldwide, accounting for around 3.23 million lost lives.Moreover, an overwhelming proportion, nearly 90%, of fatalities related to COPD in persons younger than 70 years old were concentrated in nations classified as low- and middle-income.Consequently, the intensifying spread of respiratory illnesses serves as a significant impetus for the advancement of the COPD and asthma device sectors.

What Are The Segment Types Shaping The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?

The chronic obstructive pulmonary disease (copd) and asthma devicesmarket covered in this report is segmented –

1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types

2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease

3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications

4) By End User: Pediatric, Adult, Geriatric

Subsegments:

1) By Metered Dose Inhalers: Conventional MDI, Breath-Actuated MDI

2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI), Multi-Dose DPI

3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers, Other Soft Mist Devices

4) By Jet Nebulizers: Pneumatic Nebulizers, Venturi-Type Nebulizers

5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers, Portable Ultrasonic Nebulizers

6) By Other Types: Nebulizer Accessories, Spacer Devices

What Trends Are Expected To Drive The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?

Key players within the COPD and asthma device sector are concentrating their efforts on creating novel technological solutions, particularly inhalation apparatuses, which incorporate digital health functionalities intended for remote patient observation and tailoring treatment strategies. Inhalation devices constitute medical apparatuses engineered for the direct pulmonary administration of therapeutic agents via breathing in. To illustrate this trend, the Indian pharmaceutical entity, Alkem Laboratories, launched the Innohaler, a dry powder inhaler (DPI) mechanism, in May of 2022, aiming to simplify the lives of individuals grappling with asthma and COPD. This Innohaler features sophisticated breath-actuated functionality, which guarantees pinpoint medicine deposition during every breath taken, thereby perfecting dosing precision while minimizing material wastage. Furthermore, its thoughtfully contoured physical shape facilitates simple handling, presenting an intuitive user surface that makes operation straightforward for patients spanning various age demographics. The apparatus is constructed to be both small and transportable, boosting convenience for usage while patients are moving about and consequently elevating patient compliance with prescribed therapeutic regimens.

Who Are The Core Companies Influencing The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Landscape?

Major companies operating in the chronic obstructive pulmonary disease (COPD) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, 3M Health Care, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Baxter International Inc., Omron Corporation, Smiths Medical Inc., Recipharm AB, Cipla Ltd., Teleflex Incorporated, Chiesi Farmaceutici SpA, Lincre Holdings Inc., Sunovion Pharmaceuticals Inc., Verona Pharma plc, Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-and-asthma-devices-global-market-report

Which Geographies Are Emerging As Strong Markets For The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Industry?

North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2024. The regions covered in the chronic obstructive pulmonary disease (COPD) and asthma devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=18298&type=smp

Browse Through More Reports Similar to the Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market 2025, By The Business Research Company

Chronic Disease Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chronic-disease-management-global-market-report

Chronic Lower Back Pain Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report

Chronic Obstructive Pulmonary Disease Copd Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info